Gemtuzumab Ozogamicin (GO) Inclusion to Induction Chemotherapy Eliminates Leukemic Initiating Cells and Significantly Improves Survival in Mouse Models of Acute Myeloid Leukemia

por Zhang, Cathy C, Yan, Zhengming, Pascual, Bernadette, Jackson-Fisher, Amy, Huang, Donghui Stephen, Zong, Qing, Elliott, Mark, Fan, Conglin, Huser, Nanni, Lee, Joseph, Sung, Matthew, Sapra, Puja
Publicado 2017

Epigenetic reprogramming by tumor-derived EZH2 gain-of-function mutations promotes aggressive 3D cell morphologies and enhances melanoma tumor growth

por Barsotti, Anthony M., Ryskin, Michael, Zhong, Wenyan, Zhang, Wei-Guo, Giannakou, Andreas, Loreth, Christine, Diesl, Veronica, Follettie, Maximillian, Golas, Jonathan, Lee, Michelle, Nichols, Timothy, Fan, Conglin, Li, Gang, Dann, Stephen, Fantin, Valeria R., Arndt, Kim, Verhelle, Dominique, Rollins, Robert A.
Publicado 2015